News | December 06, 2007

Studer Discharge Follow Up Software Sales Hit 100 Hospitals

December 7, 2007 - Studer Group today said its Discharge Call Manager software solution (DCM) has been purchased by 100 hospitals around the country to help improve clinical outcomes and bottom-line results by ensuring staff follows up with patients after discharge and gets quantifiable answers to specific questions.

DCM is a Web-based application that automates the framework of post-discharge calls by auto-populating patient lists, showing customized questions by area and automating results for tracking.

Prior to developing DCM, Studer Group founder Quint Studer examined evidence demonstrating that, among other things, hardwiring discharge calling into the culture of a hospital or healthcare practice reduced readmissions to the hospital within 72 hours, reduced emergency department returns within 24 hours, and dramatically increased patient satisfaction with the hospital experience.

But Studer also found that most healthcare groups were inconsistent in making discharge calls, tracking the information from the calls and generating reports to share information from the calls. The software, DCM, was designed to solve these problems. McCrory oversees installation of the software at hospital sites, helps the hospitals determine which questions to ask and track, and aids the hospitals in aggregating outcomes based on the use of DCM.

DCM works by linking to a hospital's electronic medical records and auto-populating fields so hospital staff can be alerted which patients to follow up with on which day and which questions to ask that patient.

Outcomes from the Studer Group DCM follow-up interviews showed an increased efficiency of the data input process for information from discharge calls rose from zero before implementation of DCM to 71 percent after. The company also claims efficiency of patient call-list generation (targeting which patients to call and when) rose from 5 percent before DCM to 64 percent after.

For more information: www.studergroup.com

Related Content

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Feature | Contrast Media | July 18, 2019 | By Greg Freiherr
Macrocyclic contrast agents have the best safety profile of all the magnetic resonance (MR) contrast media that are n
AAPM 2019 Features More Than 40 Presentations on ViewRay's MRIdian MRI-guided Radiotherapy
News | Image Guided Radiation Therapy (IGRT) | July 16, 2019
ViewRay Inc. announced that the company's MRIdian System is the focus of more than 40 abstracts selected by the...
FDA Approves Bayer's Gadavist Contrast for Cardiac MRI in Adult Coronary Artery Disease Patients
Technology | Contrast Media | July 15, 2019
The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic resonance...
Insightec's Exablate Neuro Approved With GE Signa Premier MRI in U.S. and Europe
News | Focused Ultrasound Therapy | July 10, 2019
GE Healthcare and Insightec announced U.S. Food and Drug Administration (FDA) approval and CE mark for Insightec’s...
Delta T1 Maps Provide Quantitative, Automated Solution to Assess Brain Tumor Burden
News | Neuro Imaging | July 05, 2019
Imaging Biometrics LLC (IB) a subsidiary of IQ-AI Ltd., is highlighting a recently published study in the American...
Medic Vision Wins Japanese PMDA Clearance for iQMR Image Reconstruction Solution
News | Magnetic Resonance Imaging (MRI) | July 05, 2019
Medic Vision Imaging Solutions announced that its 3-D iterative image reconstruction technology for shortening magnetic...
LVivo EF Comparable to MRI, Contrast Echo in Assessing Ejection Fraction
News | Cardiovascular Ultrasound | June 19, 2019
DiA Imaging Analysis announced the presentation of two studies assessing the performance and accuracy of the company's...
International Working Group Releases New Multiple Myeloma Imaging Guidelines

X-ray images such as the one on the left fail to indicate many cases of advanced bone destruction caused by multiple myeloma, says the author of new guidelines on imaging for patients with myeloma and related disorders. Image courtesy of Roswell Park Comprehensive Cancer Center.

News | Computed Tomography (CT) | June 17, 2019
An International Myeloma Working Group (IMWG) has developed the first set of new recommendations in 10 years for...
SyMRI Software Receives FDA Clearance for Use With Siemens MRI Systems
Technology | Magnetic Resonance Imaging (MRI) | June 14, 2019
SyntheticMR announced U.S. Food and Drug Administration (FDA) clearance for clinical use of its SyMRI Image and SyMRI...
A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse

Figure 1. A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse from Amsterdam Ph.D. researcher Gustav Strijkers.

News | Magnetic Resonance Imaging (MRI) | June 07, 2019
The Amsterdam University Medical Center has won MR Solutions’ Image of the Year 2019 award for the best molecular...